MarketAxess vs Oppenheimer
MKTX and OPY side by side, both in security brokers, dealers, and flotation. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How MKTX and OPY compare
MarketAxess is the larger company, worth 6.3 times as much as Oppenheimer ($5.8B against $923M).
On earnings, Oppenheimer is cheaper: it trades at 11.6× trailing earnings, against 19.5× for MarketAxess.
Oppenheimer grew revenue faster over the last twelve months (13.9% versus 3.9% for MarketAxess).
MarketAxess keeps more of each dollar of sales as profit, with a net margin of 35.2% compared with 4.9% at Oppenheimer.
Both pay dividends: MarketAxess yields 1.9% and Oppenheimer 0.88%.
MarketAxess scores higher on the StockData Score (15 against 14 for Oppenheimer), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | MKTX | OPY |
|---|---|---|
| Size and price | ||
| Market cap | $5.8B | $923M |
| Share price | $165.30 | $86.20 |
| Change, 1 year | 4.1% | 25.3% |
| Change, 5 years | −57.4% | 62.2% |
| Beta (5Y) | 0.63 | 0.82 |
| Employees | 868 | 2,947 |
| StockData Score | ||
| Total score | 15 (better) | 14 |
| Valuation score | 3 | 4 (better) |
| Growth score | 1 | 2 (better) |
| Performance score | 5 (better) | 1 |
| Health score | 4 | 4 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 19.5× | 11.6× (better) |
| P/S | 6.7× | 0.5× (better) |
| P/B | 4.7× | 0.9× (better) |
| EV/EBITDA | 13.2× | 7.1× (better) |
| P/FCF | 29.9× | 16.1× (better) |
| PEG | – | 0.16 |
| FCF yield | 3.3% | 6.2% (better) |
| Fair value | $197.31 | $114.09 |
| Margin of safety | 16.2% | 24.4% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.9% | 13.9% (better) |
| Revenue growth, 5Y average | 4.2% | 6.4% (better) |
| Net income growth (TTM) | 37.5% (better) | 2.2% |
| EPS growth (TTM) | 42.8% (better) | −0.94% |
| EPS growth, 5Y average | −3.3% | 7.0% (better) |
| Profitability | ||
| Operating margin | 40.5% (better) | 7.2% |
| Net margin | 35.2% (better) | 4.9% |
| FCF margin | 22.3% (better) | 3.3% |
| Return on equity | 23.3% (better) | 9.1% |
| Return on invested capital | 29.0% (better) | 9.4% |
| Financial health | ||
| Debt / equity | 0.09 (better) | 0.00 |
| Net debt / EBITDA | −0.30 | – |
| Interest coverage | 59.9× | – |
| Altman Z-score | 4.77 (better) | 1.04 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.9% (better) | 0.88% |
| Payout ratio | – | 21.5% |
| Years of dividend growth | 12 (better) | 2 |
| Dividend growth, 5Y average | 4.8% (better) | −13.4% |
| Buyback yield | 5.9% (better) | 0.25% |
| Shareholder yield | 7.8% (better) | 1.1% |
| Ownership | ||
| Held by institutions | 111% | 41.7% |
| Held by insiders | 2.5% | 6.0% |
| Insider net buying, 12 months | −$1.2M | −$420K (better) |
| Short interest, % of float | 9.3% | 0.98% |
Go deeper
- MKTX stock overview
- MKTX income statement
- MKTX valuation and score
- OPY stock overview
- OPY income statement
- OPY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.